THE THYMUS GLAND (THYMUS) ASPECTS IN CHILDREN (PART IV). TIMUS AND COVID-19
Main Article Content
Abstract
At this stage in the development of immunology, it is still difficult to draw the line between the functions of the central and peripheral organs of the immune system, cell populations of the hematopoietic system, neuro-endocrine and connective tissue, which ensure the constancy of the internal environment, nonspecific defense factors (etc.). However less, time will solve this problem and there will be a possibility of complementary therapeutic and prophylactic control over the infectious process, tumor growth, autoaggression, organ and tissue transplantation, etc.This article is an attempt to get closer to understanding the main or indirect role of the thymus gland in the complex reciprocal process of interaction of the above organs and systems in countering such a viral infection as COVID-19.
Keywords
Author Biographies
Юрий Иванович Ровда,
Rovda Yuryi Ivanovich
MD, PhD, professor
He is the Honoured Doctor of the Russian Federation, the Head of the Department of Pediatrics and Neonatology. He graduated from the Pediatric Faculty of Kemerovo Medical Institute in 1973. On his initiative the Regional Pediatric Cardiac Center was organized. His researches concerning the metabolic syndrome, purinosis, hypertension in children are priorities in the Russian Federation.
He is an expert of the Russian Task Group of Federal Service on Surveillance in Healthcare, dealing with mentioned diseases.
He was the first who developed and implemented method of diagnostics of visceral fat deposition in children with echocardiography and a number of different new scientific-practical methods (the prevention of purine metaboliс imbalance, prenosological diagnostics and prevention of arterial hypertension and metabolic syndrome in children and adolescents, alternative methods of prevention and treatment of metabolic syndrome, allergodermia in children – ozone therapy, etc.).Алена Владимировна Ведерникова,
assistant, department of pediatrics and neonatologyНаталья Николаевна Миняйлова,
doctor of medical sciences, docent, professor for department of pediatrics and neonatologyАндрей Владимирович Шабалдин,
doctor of medical sciences, docent, professor of the department of polyclinic pediatrics, propedeutics of children diseases and postgraduate trainingОльга Валерьевна Шмакова,
candidate of medical sciences, docent, head of the department of pediatrics and neonatologyНаталья Степановна Черных,
candidate of medical sciences, docent, docent of the department of polyclinic pediatrics, propaedeutics of children diseases and postgraduate trainingВероника Павловна Строева,
candidate of medical sciences, docent, docent of the department of pediatrics and neonatologyArticle Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Cao Q, Chen YC, Chen CL, Chiu CH. SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020; 119: 670-673
Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007; 211: 144-156
Garly ML, Trautner SL, Marx C, Danebod K, Nielsen J, Ravn H, et al. Thymus size at 6 months of age and subsequent infant mortality. J Pediatr. 2008; 153: 683-688
Drabkin MJ, Meyer JI, Kanth N, Lobel S, Fogel J, Grossman J, Krumenacker JH. Age-stratified patterns of thymic involution on multidetector CT. J Thorac Imaging. 2018; 33: 409-416
Zhang Y, Chua SJr. Leptin function and regulation. Compr Physiol. 2017; 8(1): 351-369
Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007; 211: 144-156
Güneş H, Dinçer S, Acıpayam C, Yurttutan S, Özkars MY. What chances do children have against COVID-19? Is the answer hidden within the thymus? Eur J Pediatr. 2021; 180(3): 983-986. doi: 10.1007/s00431-020-03841-y
Palmer S, Cunniffe N, Donnelly R. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production. J R Soc Interface. 2021; 18(176): 20200982. doi: 10.1098/rsif.2020.0982
Kellogg C, Equils O. The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization. Hum Vaccin Immun other. 2021; 17(3): 638-643. doi: 10.1080/21645515.2020.1818519
Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998; 396(6712) :690-695. doi:10.1038/25374
Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LW. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol. 1993; 150: 1105-1121
Çakmak V, Yılmaz A, Sarı T, Çakmak P, Özen M, Herek D, Oskay A. Evaluation of the chest computed tomography and hemogram data in patients with COVID-19: the importance of thymus. Turk J Med Sci. 2021; 51(3): 991-1000. doi: 10.3906/sag-2007-306
Wang W, Thomas R, Oh J, Su DM. Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly. Cells. 2021; 10(3): 628. doi: 10.3390/cells10030628
Raynor J, Lages CS, Shehata H, Hildeman DA, Chougnet CA. Homeostasis and function of regulatory T cells in aging. Curr Opin Immunol. 2012; 24: 482-487
Tsukamoto H, Clise-Dwyer K, Huston GE, Duso DK, Buck AL, Johnson LL, et al. Age-associated increase in lifespan of naive CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects. Proc Natl Acad Sci USA. 2009; 106: 18333-18338
Chougnet CA, Tripathi P, Lages CS, Raynor J, Sholl A, Fink P, et al. A Major Role for Bim in Regulatory T Cell Homeostasis. J Immunol. 2010; 186: 156-163
Lins, MP, Smaniotto S. Potential impact of SARS-CoV-2 infection on the thymus. Can J Microbiol. 2020; 67: 1-6
Wang K, Chen W, Zhou YS, Lian JQ, Zhang Z, Du P, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv. 2020 [In press]
Heshui Shi, Xiaoyu Han, Nanchuan Jiang, Yukun Cao, Osamah Alwalid, Jin Gu, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20(4): 425-434. doi: 10.1016/S1473-3099(20)30086-4
Hin Chu, Jie Zhou, Bosco Ho-Yin Wong, Cun Li, Zhong-Shan Cheng, Xiang Lin, et al. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology. 2014; 454-455: 197-205. doi: 10.1016/j.virol.2014.02.018
Zhou J, Chu H, Li C, Wong BHY, Cheng ZS, Poon VKM, Sun T, Lau CCY, Wong KKY, Chan JYW, Chan JFW, To KKW, Chan KH, Zheng BJ, Yuen KY. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis. 2014; 209: 1331-1342
Yaqinuddin A, Kashir J. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents. Med Hypotheses. 2020; 140: 109777. doi: 10.1016/j. mehy.2020.109777
Cuvelier P, Roux H, Couëdel-Courteille A, Dutrieux J, Naudin C, Charmeteau de Muylder B, et al. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome. Crit Care. 2021; 25(1): 4. doi: 10.1186/s13054-020-03440-1
Abramov D. (2021) Scientists have determined the specificity of the immune response to coronavirus //website ria.ru 09/21/2021. Russian (Абрамов Д. (2021) Ученые определили специфику иммунного ответа на коронавирус //сайт ria.ru 21.09.2021) https://ria.ru/20210921/koronavirus-1751133569.html
Bregel LV, Kostik MM, Fell LZ, Efremova OS, Soboleva MK, Krupskaya TS, Matyunova AE. Kawasaki disease and multisystem inflammatory syndrome in children with COVID-19 infection. Pediatrics. 2020; 99(6): 209-219. Russian (Брегель Л.В., Костик М.М., Фелль Л.З., Ефремова О.С., Соболева М.К., Крупская Т.С., Матюнова А.Е. Болезнь Кавасаки и мультисистемный воспалительный синдром при инфекции COVID-19 детей //Педиатрия. 2020. Т. 99, № 6. С. 209-219.) doi: 10.24110/0031-403X-2020-99-6-209-219
Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association. Eur Heart J. 2020; 41: 1858
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones C, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020; 324(3): 259-269
Bunyavanich S, DoA, VicencioA. Nasal Gene Expres – sion of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA. 2020; 323(23): 2427-2429
Sharif-Askari NS, Sharif-Askari FS, Alabed M, Temsah M-H, Al Heialy S, Hamid Q, Halwani R. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRS S2 Is Lower in Children Than Adults and Increases with Smoking and COPD. Mol Ther Methods Clin Dev. 2020; 18: 1-6. doi: 10.1016/j.omtm.2020.05.013
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17(5): 259-260
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5): 2620-2629
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020; 92(4): 424-432
Wang X, Xu W, Hu G, Xia S, Sun Z, Liu Z, et al. RETRACTED ARTICLE: SARS-CoV-2 infects T-lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020; 1-3: https://doi.org/10.1038/s41423-020-0424-9
Manjili RH, Zarei M, Habibi M, Manjili MH. COVID-19 as an Acute Inflammatory Disease. J Immunol. 2020; 205(1): 12-19
Wu L, O'Kane AM, Peng H, Bi Y, Motriuk-Smith D, Ren J. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. Biochem Pharmacol. 2020; 178: 114114
Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506
Rüster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006; 17(11): 2985-2991
Liu X, Liu Y, Wang L, Hu L, Liu D, Li J. Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective study. J Med Virol. 2021; 93(3): 1573-1580. doi: 10.1002/jmv.26492
Naylor PH, Mutchnick MG. Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosinα1 efficacy trials in the light of a combination therapy approach. J Viral Hepat. 2018; 25(1): 4-9
Matteucci C, Grelli S, Balestrieri E, Minutolo A, Argaw-Denboba A, Macchi B, et al. Thymosin alpha 1 and HIV-1: recent advances and future perspectives. Future Microbiol. 2017; 12(2): 141-155. doi: 10.2217/fmb-2016-0125
Yueping Liu, Yue Pan, Zhenhong Hu, Ming Wu, Chenhui Wang, Zeqing Feng, et al. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells. Clin Infect Dis. 2020; 71(16): 2150-2157. doi: 10.1093/cid/ciaa630
Khavinson VK, Kuznik BI, Trofimova SV, Volchkov VA, Rukavishnikova SA, Titova ON, et al. Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19. Stem Cell Rev Rep. 2021; 17(1): 285-290. doi: 10.1007/s12015-020-10087-6
Henson SM, Snelgrove R, Hussell T, Wells DJ, Aspinall R. An IL-7 Fusion Protein That Shows Increased Thymopoietic Ability. J Immunol. 2005; 175: 4112-4118
Laterre PF, François B, Collienne C, Hantson P, Jeannet R, Remy KE, Hotchkiss RS. Association of Interleukin 7 Immunotherapy with Lymphocyte Counts Among Patients with Severe Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020; 3: e2016485
Monneret G, De Marignan D, Coudereau R, Bernet C, Ader F, Frobert E, et al. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient. Cell Mol Immunol. 2020; 17: 1001-1003
Lages CS, Lewkowich I, Sproles A, Wills-Karp M, Chougnet C. Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway. Aging Cell. 2010; 9: 785-798
Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, et al. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009; 460(7251): 108-112. doi: 10.1038/nature08155
Mannick JB, Morris M, Hockey H-U.P, Roma G, Beibel M, Kulmatycki K, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 2018; 10(449): eaaq1564. doi: 10.1126/scitranslmed.aaq1564
Kennedy RB, Ovsyannikova IG, Haralambieva IH, Oberg AL, Zimmermann MT, Grill DE, Poland GA. Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination. Front Immunol. 2016; 7: 450
Maciolek J, Pasternak JA, Wilson HL. Metabolism of activated T lymphocytes. Curr Opin Immunol. 2014; 27: 60-74
Elahi A, Sabui S, Narasappa NN, Agrawal S, Lambrecht NW, Agrawal A, Said HM. Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. J Immunol. 2018; 200: 2563-2570
Zhang F, Liu G, Li D, Wei C, Hao J. DDIT4 and Associated lncDDIT4 Modulate Th17 Differentiation through the DDIT4/TSC/mTOR Pathway. J Immunol. 2018; 200: 1618-1626
Tang L, Yin Z, Hu Y, Mei H. Controlling Cytokine Storm Is Vital in COVID-19. Front Immunol. 2020; 11: 570993
Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, et al. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation. Neuroscientist. 2020; 26: 402-414
Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. High TNF-α levels in resting B cells negatively correlate with their response. Exp Gerontol. 2014; 54: 116-122
Khan SI, Shihata WA, Andrews KL, Lee MKS, Moore X-L, Jefferis A-M, et al. Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat. FASEB J. 2019; 33(1): 1510-1521. doi: 10.1096/fj.201701498RR
Alexia C, Cren M, Louis-Plence P, Vo D-N, El Ahmadi Y, Dufourcq-Lopez E, et al. Polyoxidonium® activates cytotoxic lymphocyte responses through dendritic cell maturation: Clinical effects in breast cancer. Front Immunol. 2019; 10: 2693. doi: 10.3389/fimmu.2019. 02693
Talayev VYu, Matveichev AV, Zaichenko IE, Talaeyva MV, Babaykina ON, Voronina EV. Polyoxidonium® vaccine adjuvant enhances the immune response to low dose of influenza antigens. Scientific support of anti-epidemic protection of the population: urgent problems and solutions: collection of scientific papers. Nizhny Novgorod: Remedium Volga Region, 2019. P. 363-365. Russian (Талаев В.Ю., Матвеичев А.В., Заиченко И.Е., Талаева М.В., Бабайкина О.Н., Воронина Е.В. Вакцинный адъювант Полиоксидоний® усиливает иммунный ответ на низкую дозу антигенов гриппа //Научное обеспечение противоэпидемической защиты населения: актуальные проблемы и решения: сборник научных трудов. Н.Новгород: Ремедиум Приволжье, 2019. С. 363-365)
Kostinov MP, Markelova EV, Svitich OA, Polishchuk VB. Immune mechanisms of SARS-CoV-2 and potential drugs in the prevention and treatment of COVID-19. Pulmonology. 2020; 30(5): 700-708. Russian (Костинов М.П., Маркелова Е.В., Свитич О.А., Полищук В.Б. Иммунные механизмы SARS-CoV-2 и потенциальные препараты для профилактики и лечения COVID-19 //Пульмонология. 2020. Т. 30, № 5. С. 700-708)